Literature DB >> 7829392

High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection.

T Suzuki1, K Shidara, F Hara, T Nakajima.   

Abstract

A series of 41 laryngeal squamous cell carcinomas was examined for p53 abnormalities and human papillomavirus (HPV) infection by an immunohistochemical and/or molecular approach. Immunohistochemically, p53 over-expression was observed in about 60% of the cancers, of which 12 were revealed to contain point mutations of p53 by a combination of the single-strand conformational polymorphism technique and direct sequencing. The p53 point mutations ranged from codons 157 to 278 and most of these mutations lay in two "hot spots" (codon 157 in four cancers and codon 248 in three cancers). The majority of p53 mutations, both transversions (seven cancers) and transitions (five cancers), occurred at the G nucleotide of the codons. An analysis of the clinical information indicated that p53 point mutation was frequently observed in heavy smokers with an average Brinkman index score of more than 1000. On the other hand, HPV DNA, type 16 or 18, was detected in a quarter of the laryngeal cancers. Of eleven HPV-positive cases, nine were immunohistochemically positive for p53, of which four contained a p53 point mutation. These results suggested no inverse relation between p53 mutation and HPV infection in laryngeal cancers. Our study indicates that p53 abnormalities are related to smoking history and the correlation might be better for smoking and chemical mutagenesis than for HPV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829392      PMCID: PMC5919361          DOI: 10.1111/j.1349-7006.1994.tb02911.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  40 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.

Authors:  R Maestro; R Dolcetti; D Gasparotto; C Doglioni; S Pelucchi; L Barzan; E Grandi; M Boiocchi
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene.

Authors:  R H Chen; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

8.  Over-expression of p53 protein in human laryngeal carcinoma.

Authors:  K Anwar; K Nakakuki; H Imai; H Naiki; M Inuzuka
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

9.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

10.  Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.

Authors:  H Tsuda; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-11
View more
  1 in total

1.  Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Authors:  Brenda Y Hernandez; Marc T Goodman; Charles F Lynch; Wendy Cozen; Elizabeth R Unger; Martin Steinau; Trevor Thompson; Maria Sibug Saber; Sean F Altekruse; Christopher Lyu; Mona Saraiya
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.